Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Yuri Ono, Hikaru Kamoshima, Akinobu Nakamura & Hiroshi Nomoto. (2014) Glycemic/metabolic responses to identical meal tolerance tests at breakfast, lunch and dinner in Japanese patients with type 2 diabetes mellitus treated with a dipeptidyl peptidase-4 inhibitor and the effects of adding a mitiglinide/voglibose fixed-dose combination. Expert Opinion on Pharmacotherapy 15:13, pages 1785-1795.
Read now
Read now
Takeshi Osonoi, Miyoko Saito, Atsuko Tamasawa, Hidenori Ishida & Yusuke Osonoi. (2014) Effects of sitagliptin or mitiglinide as an add-on to acarbose on daily blood glucose fluctuations measured by 72 h subcutaneous continuous glucose monitoring in Japanese patients with type 2 diabetes: a prospective randomized study. Expert Opinion on Pharmacotherapy 15:10, pages 1325-1335.
Read now
Read now
Kohei Kaku. (2014) Efficacy of voglibose in type 2 diabetes. Expert Opinion on Pharmacotherapy 15:8, pages 1181-1190.
Read now
Read now
Yuri Ono, Akinobu Nakamura, Kyu Yong Cho & Hiroshi Nomoto. (2014) The glycemic/metabolic responses to meal tolerance tests at breakfast, lunch and dinner, and effects of the mitiglinide/voglibose fixed-dose combination on postprandial profiles in Japanese patients with type 2 diabetes mellitus. Expert Opinion on Pharmacotherapy 15:3, pages 311-324.
Read now
Read now
Akio Ohta, Toshihiko Ohshige, Kensuke Sakai, Yuta Nakamura, Ayumi Tenjin, Shuichi Tsukiyama, Yuko Terashima, Fumiaki Matsubara, Takehiro Kawata, Yoshio Nagai & Yasushi Tanaka. (2013) Comparison of the hypoglycemic effect of sitagliptin versus the combination of mitiglinide and voglibose in drug-naïve Japanese patients with type 2 diabetes. Expert Opinion on Pharmacotherapy 14:17, pages 2315-2322.
Read now
Read now
Hiroyuki Konya, Tomoyuki Katsuno, Taku Tsunoda, Yuzo Yano, Mai Kamitani, Masayuki Miuchi, Tomoya Hamaguchi, Jun-Ichiro Miyagawa & Mitsuyoshi Namba. (2013) Effects of combination therapy with mitiglinide and voglibose on postprandial plasma glucose in patients with type 2 diabetes mellitus. Diabetes, Metabolic Syndrome and Obesity 6, pages 317-325.
Read now
Read now
Articles from other publishers (8)
Toshihito Ando, Masaki Kondo, Yuriko Asada-Yamada, Miyuka Kawai, Emi Asano-Hayami, Tomohide Hayami, Mikio Motegi, Yohei Ejima, Eriko Nagao, Rina Kasagi, Hiromi Nakai-Shimoda, Saeko Asano, Makoto Kato, Yuichiro Yamada, Emiri Yura-Miura, Takahiro Ishikawa, Yukako Sugiura-Roth, Chika Kojima, Ena Naito, Tatsuhito Himeno, Shin Tsunekawa, Yoshiro Kato, Jiro Nakamura & Hideki Kamiya. (2023) The efficacy of switching basal–bolus insulin therapy to basal insulin-supported oral therapy with a glinide and an α-glucosidase inhibitor in patients with type 2 diabetes depends on insulin secretory capacity, but not on blood glucose profiles and insulin dosages prior to the switching. Diabetology International.
Crossref
Crossref
Hiroshi Okada, Muhei Tanaka, Goji Hasegawa, Hanako Nakajima, Mayuko Kadono, Yuki Okada, Atsuhiro Hirata, Hirokazu Oyamada, Tetsuro Yamane & Michiaki Fukui. (2020) Comparison of the Efficacy of Repaglinide Versus the Combination of Mitiglinide and Voglibose on Glycemic Variability in Japanese Patients with Type 2 Diabetes. Current Pharmaceutical Design 25:43, pages 4600-4605.
Crossref
Crossref
Mai Sotoyama, Shinya Uchida, Chiaki Kamiya, Shimako Tanaka, Yasuharu Kashiwagura, Akio Hakamata, Keiichi Odagiri, Naoki Inui, Hiroshi Watanabe & Noriyuki Namiki. (2019) Ease of Taking and Palatability of Fixed-Dose Orally Disintegrating Mitiglinide/Voglibose Tablets. Chemical and Pharmaceutical Bulletin 67:6, pages 540-545.
Crossref
Crossref
Tadashi ARAO, Yosuke OKADA, Keiichi TORIMOTO, Kei SUGAI, Takashi OTSUKA, Akira KUROZUMI & Yoshiya TANAKA. (2017) Comparison Between Effectiveness of 100 mg/day Sitagliptin and a Switch to Mitiglinide Calcium Hydrate/Voglibose from 50 mg/day Sitagliptin in Patients with Type 2 Diabetes2型糖尿病患者におけるシタグリプチン50 mgから100 mgへの増量とミチグリニドカルシウム水和物・ボグリボースへの切り替えにおける有用性に関する比較検討. Journal of UOEH 39:1, pages 1-9.
Crossref
Crossref
Noriko Ihana-Sugiyama, Ritsuko Yamamoto-Honda, Takehiro Sugiyama, Tetsuro Tsujimoto, Masafumi Kakei & Mitsuhiko Noda. (2017) Cross-Over Study Comparing Postprandial Glycemic Increase After Addition of a Fixed-Dose Mitiglinide/Voglibose Combination or a Dipeptidyl Peptidase-4 Inhibitor to Basal Insulin Therapy in Patients with Type 2 Diabetes Mellitus. Medical Science Monitor Basic Research 23, pages 36-44.
Crossref
Crossref
Xiaolong Chen, Yuele Lu, Yongxian Fan & Yinchu Shen. 2017. Validamycin and its Derivatives. Validamycin and its Derivatives
237
278
.
Shaheena Banu, Nasimudeen R. Jabir, Nanjappa C. Manjunath, Mohd Shahnawaz Khan, Ghulam Md Ashraf, Mohammad Amjad Kamal & Shams Tabrez. (2015) Reduction of post-prandial hyperglycemia by mulberry tea in type-2 diabetes patients. Saudi Journal of Biological Sciences 22:1, pages 32-36.
Crossref
Crossref
Kohei Kaku, Nobuya Inagaki & Naoki Kobayashi. (2014) Long-term Effects of Mitiglinide in Japanese Diabetics Inadequately Controlled with DPP-4 Inhibitor or Biguanide Monotherapy. Diabetes Therapy 5:1, pages 97-111.
Crossref
Crossref